GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Paper] SURMOUNT-4 withdrawal arm, read the appendix not the abstract — 27 comments in the full submission. View in context.
305
c/trialwatch·submitted 5 days ago by u/camila_vasquez

[Paper] SURMOUNT-4 withdrawal arm, read the appendix not the abstract

Paperbranch of 10 comments

Trying to settle this properly because the thread from last year went in circles. The claim: FLOW matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 24 months without either producing anything. What would actually settle it is 35 people measuring the same…

Read the full submission and all 27 comments →

This branch

10 comments, started 3 days ago
u/hub_opssite staff15 points·3 days ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/anders_kuusela5 points·3 days ago·edited

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/joaquin_trevino1 point·3 days ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/eu_apotheke_a1 point·2 days ago

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
u/renal_outcomes_rnephro-curious1 point·2 days ago

Which trial and what was the primary endpoint?

replysharereportpermalink
u/yusuf_ramos12 points·3 days ago

Is that absolute or relative risk reduction?

replysharereportpermalink
u/bastian_ekstrom7 points·3 days ago

event rates are more informative than hazard ratios alone

replysharereportpermalink
u/anders_karlsen2 points·3 days ago·edited

event rates are more informative than hazard ratios alone

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/forest_plot_fionastats4 points·2 days ago

absolute risk reduction, not relative risk reduction, that is how you decide

replysharereportpermalink
u/yannick_salinas6 points·3 days ago

Yeah, absolute numbers matter more than the press release.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.